Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Andrew McGarry, Shane Rosanbalm, Mika Leinonen, C. Warren Olanow, Dennis To, Adam Bell, Daniel J. Lee, Jamie Chang, Jordan Dubow, Rohit Dhall, Daniel J. Burdick, Sotirios A. Parashos, Jeanne Feuerstein, Joseph F. Quinn, Rajesh Pahwa, Mitra Afshari, Aldolfo Ramirez-Zamora, Kelvin L. Chou, Arjun Tarakad, Corneliu Luca, Kevin J. Klos, Yvette Bordelon, Marie-Helene St Hiliare, David Shprecher, Seulki Lee, Ted M. Dawson, Viktor Roschke, Karl Kieburtz